17-ID-206: A Phase 4 Study to Assess the Safety and Immunogenicity of VAXCHORA (Cholera Vaccine, Live, Oral) in Children 2 to <18 Years of Age (PXVX-VC-200-006)

Grants and Contracts Details

StatusFinished
Effective start/end date8/17/178/1/19

Funding

  • PaxVax Incorporated: $17,000.00